Posted on March 8, 2022

Investors are talking about Psychedelics. No, they aren’t tripping

By Greg

About the Author

Healthcare companies are looking to use psychedelic drugs to help treat mental health disorders. Here’s why investors are taking notice and what you may wish to know about this space.

Oklahoma House Passes Psilocybin Decriminalization And Research Bill, Sending It To Senate By: Greg

JOIN THE CONVERSATION

Whether you’re a fungi fledgling or a mature mycophile, you’re in good company. Join our community’s discussion about all things mushroom.

Sign up to our newsletter to get the science and views around life-changing innovations for mind and body.

Join Us

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Investors are talking about Psychedelics. No, they aren’t tripping

By Greg

Oklahoma House Passes Psilocybin Decriminalization And Research Bill, Sending It To Senate By: Greg

The Gold Standard for Psychedelic-Assisted Therapy? By: Greg

JOIN THE CONVERSATION

Whether you’re a fungi fledgling or a mature mycophile, you’re in good company. Join our community’s discussion about all things mushroom.

RELATED ARTICLES

EDITOR'S PICKS

Ketamine Therapy: The History and the Future By: Beatrice Society

Bill Richards: Psychedelic Therapy and the Perfect Psilocybin Playlist By: Ben Rayner

Different Psilocybin Dosage Effects: What do they Feel Like? By: Tom Buchanan

Sign up to our newsletter to get the science and views around life-changing innovations for mind and body.